Tezspire (tezepelumab-ekko) is a thymic stromal lymphopoietin blocker human monoclonal antibody indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma.

If you have a Hayes login, click here to view the full report on the Knowledge Center.